Shai Shimony, MD

Medical Oncology

Shai Shimony, MD

View full profile

Related Videos

Shai Shimony, MD, MPH reviews Phase 3 acute myeloid leukemia trial Video

Shai Shimony, MD, MPH reviews Phase 3 acute myeloid leukemia trial

Findings from a Phase 3 acute myeloid leukemia trial presented at #ASH24 show CPX-351 improves survival for AML-MR patients. Lead authors Shai Shimony, MD, MPH, and H. Moses Murdoch, MD, of Dana-Farber Cancer Institute, explain more in this video.

Shai Shimony, MD, Molecular Ontogeny in AML Video

Shai Shimony, MD, Molecular Ontogeny in AML

A study led by Shai Shimony, MD, Dana-Farber, revealed the significant impact of molecular ontogeny classification on outcomes among newly diagnosed acute myeloid leukemia patients treated with hypomethylating agents (HMA) +/- venetoclax (VEN).